ResearcherWayne State UniversityActive in the last 2 years

Rayane Dennaoui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5776-252X; OpenAlex author ID A5075763002. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

The Janus kinase 1 is critical for pancreatic cancer initiation and progression. Co-author DOI 10.1016/j.celrep.2024.114202 ↗
Models of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s10555-021-09989-9 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hridaya Shrestha · 2 shared papers, 2021–2024 · strength 0.41
- Paper Models of pancreatic ductal adenocarcinoma. DOI 10.1007/s10555-021-09989-9 ↗
- Paper The Janus kinase 1 is critical for pancreatic cancer initiation and progression. DOI 10.1016/j.celrep.2024.114202 ↗
Kay‐Uwe Wagner · 2 shared papers, 2021–2024 · strength 0.41
- Paper Models of pancreatic ductal adenocarcinoma. DOI 10.1007/s10555-021-09989-9 ↗
- Paper The Janus kinase 1 is critical for pancreatic cancer initiation and progression. DOI 10.1016/j.celrep.2024.114202 ↗
Nirakar Rajbhandari · 1 shared paper, 2024 · strength 0.18
- Paper The Janus kinase 1 is critical for pancreatic cancer initiation and progression. DOI 10.1016/j.celrep.2024.114202 ↗
Dieter Saur · 1 shared paper, 2024 · strength 0.18
- Paper The Janus kinase 1 is critical for pancreatic cancer initiation and progression. DOI 10.1016/j.celrep.2024.114202 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.